Certuity LLC Boosts Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Certuity LLC raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.3% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 10,650 shares of the exchange traded fund’s stock after buying an additional 540 shares during the period. Certuity LLC’s holdings in SPDR S&P Biotech ETF were worth $987,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. HBK Sorce Advisory LLC boosted its holdings in SPDR S&P Biotech ETF by 2.6% during the first quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock worth $431,000 after buying an additional 113 shares in the last quarter. Intellectus Partners LLC boosted its stake in shares of SPDR S&P Biotech ETF by 1.0% during the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock worth $1,051,000 after acquiring an additional 113 shares in the last quarter. Concourse Financial Group Securities Inc. grew its position in shares of SPDR S&P Biotech ETF by 21.2% during the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock valued at $59,000 after acquiring an additional 115 shares during the period. Pacific Center for Financial Services grew its position in shares of SPDR S&P Biotech ETF by 2.8% during the 1st quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock valued at $414,000 after acquiring an additional 118 shares during the period. Finally, Kingsview Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 3.8% in the 1st quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after purchasing an additional 127 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 1.6 %

Shares of XBI stock opened at $96.52 on Friday. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The business’s 50 day moving average is $97.74 and its two-hundred day moving average is $93.81. The company has a market capitalization of $7.36 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.